Quick Comparison

Huperzine AHuperzine A
Half-Life10-14 hours10-14 hours
Typical DosageStandard: 50-200 mcg once or twice daily. Due to the long half-life, cycling is recommended (2 weeks on, 1 week off). Do not combine with prescription acetylcholinesterase inhibitors (donepezil, rivastigmine).Standard: 50-200 mcg once or twice daily. Due to the long half-life, cycling is recommended (2 weeks on, 1 week off). Do not combine with prescription acetylcholinesterase inhibitors (donepezil, rivastigmine).
AdministrationOral (capsules, tablets). Well-absorbed orally.Oral (capsules, tablets). Well-absorbed orally.
Research Papers10 papers10 papers
Categories

Mechanism of Action

Huperzine A

Huperzine A is a potent, selective, and reversible inhibitor of acetylcholinesterase (AChE), binding to the enzyme's active site and preventing hydrolysis of acetylcholine to choline and acetate. By blocking AChE, it increases acetylcholine concentration in the synaptic cleft, prolonging activation of muscarinic (M1-M5) and nicotinic receptors. Huperzine A also blocks NMDA glutamate receptors in a non-competitive, use-dependent manner (similar to memantine), binding to the phencyclidine site within the ion channel and protecting neurons from excitotoxic calcium influx. It shows selectivity for the NR2A and NR2B subunits. Additionally, huperzine A has antioxidant properties, scavenging reactive oxygen species and reducing lipid peroxidation. It may enhance NGF signaling.

Huperzine A

Huperzine A is a potent, selective, and reversible inhibitor of acetylcholinesterase (AChE), binding to the enzyme's active site and preventing hydrolysis of acetylcholine to choline and acetate. By blocking AChE, it increases acetylcholine concentration in the synaptic cleft, prolonging activation of muscarinic (M1-M5) and nicotinic receptors. Huperzine A also blocks NMDA glutamate receptors in a non-competitive, use-dependent manner (similar to memantine), binding to the phencyclidine site within the ion channel and protecting neurons from excitotoxic calcium influx. It shows selectivity for the NR2A and NR2B subunits. Additionally, huperzine A has antioxidant properties, scavenging reactive oxygen species and reducing lipid peroxidation. It may enhance NGF signaling.

Risks & Safety

Huperzine A

Common

Nausea, diarrhea, sweating, muscle twitching.

Serious

Cholinergic crisis at high doses (excessive acetylcholine causing muscle weakness, breathing difficulty).

Rare

Blurred vision, slowed heart rate, seizures.

Huperzine A

Common

Nausea, diarrhea, sweating, muscle twitching.

Serious

Cholinergic crisis at high doses (excessive acetylcholine causing muscle weakness, breathing difficulty).

Rare

Blurred vision, slowed heart rate, seizures.

Full Profiles